Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient‐Centered Prescribing
Journal of the American Geriatrics Society · 29.10.2026
DOI: 10.1111/jgs.70769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 29.10.2026. Verfasst von Elias M Wisdom und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Oregon Health & Science University, Portland, Oregon, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: NIA NIH HHS, Abbott Nutrition and Advarra, NIDDK NIH HHS.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Obesity medications that act through gut‐derived hormonal pathways include glucagon‐like peptide‐1 receptor agonists (GLP‐1), dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonists (GLP‐1/GIP), and emerging triple glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide/glucagon receptor agonists. These therapies are increasingly prescribed for weight management and glycemic control, as well as for their cardiometabolic and renal benefits. While these medications offer substantial benefits to patients across multiple health conditions, their use in older adults warrants heightened scrutiny. Older adults face increased risks of sarcopenia and frailty, and evidence from major clinical trials suggests that a substantial proportion of medication‐associated weight loss agents may result in loss of lean mass, potentially posing risks for this population. Other adverse effects that may be more consequential in older adults include dehydration, malnutrition, perioperative aspiration, and fat‐predominant weight regain after discontinuation. This paper provides a clinically oriented framework to guide prescribing decisions for older adults. Drawing on patient scenarios from common geriatric contexts, including frailty, cognitive impairment, glucocorticoid use, and surgical planning, we propose prescribing approaches that optimize therapeutic benefits while mitigating potential harms. We integrate these recommendations within the Geriatrics 5Ms Framework (Mind, Mobility, Medications, Multicomplexity, and Matters Most) to contextualize treatment within geriatrics practice. Lifestyle co‐interventions, particularly resistance training, adequate protein intake, and ongoing functional monitoring, emerge as essential components for older adults receiving these therapies. We also discuss identifying priority areas for future research, including age‐stratified clinical trials and the routine inclusion of body composition and physical function outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Scientist Training Program, Oregon Health & Science University, Portland, Oregon, USA.
- Department of Geriatric and Internal Medicine, Sinai Health/University Health Network, Toronto, Ontario, Canada.
- University of Toronto, Toronto, Ontario, Canada.
- Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA.
- Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
- Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
ORCID-Profile: John A Batsis
Förderung
- NIA NIH HHS
- Abbott Nutrition and Advarra
- NIDDK NIH HHS
Zitieren
APA
Wisdom, E. M., Goldlist, K., Lieber, S. B., Marwell, J., Neukam, S., Johnston, E. A., Batsis, J. A., Eckstrom, E., & Wagle, K. C. (2026). Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient‐Centered Prescribing. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.70769
Vancouver
Wisdom EM, Goldlist K, Lieber SB, Marwell J, Neukam S, Johnston EA, et al. Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient‐Centered Prescribing. Journal of the American Geriatrics Society. 2026. doi:10.1111/jgs.70769
BibTeX
@article{Wisdom2026,
author = {Wisdom, Elias M and Goldlist, Kady and Lieber, Sarah B and Marwell, Julianna and Neukam, Suvi and Johnston, Emily A and Batsis, John A and Eckstrom, Elizabeth and Wagle, Kamal Chandra},
title = {Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient‐Centered Prescribing},
journal = {Journal of the American Geriatrics Society},
year = {2026},
doi = {10.1111/jgs.70769}
}
EUVIMED